Cetilar® Nutrition confirmed as Official Nutrition Partner of the 2026 Giro d’Italia

Second year as Official Nutrition Partner for the most demanding Corsa Rosa ever

Following yesterday’s official route presentation at the Auditorium Parco della Musica in Rome, the 2026 Giro d’Italia enters its operational phase, and for the second consecutive year it will rely on the support of Cetilar^® Nutrition as Official Nutrition Partner of the Giro d’Italia and its associated races: Giro d’Italia Women, Giro-E and Giro Next Gen.

The collaboration is part of the 2025–2027 three-year agreement signed between Pharmanutra and RCS Sport, and it is reaffirmed today in what promises to be one of the most challenging editions of the Corsa Rosa: 3,459 km of racing and 50,000 meters of total elevation gain, from the Grand Départ in Bulgaria all the way to the Grande Arrivo in Rome.

A highly intensive route for the 2026 Giro d’Italia

Beyond the opening three stages in Bulgaria, the 2026 Giro d’Italia route features a demanding sequence of flat, medium-mountain, and high-mountain stages, including seven summit finishes and a 40.2 km individual time trial between Viareggio and Massa.

For the athletes, this means facing prolonged efforts, extreme elevation changes, and highly variable environmental conditions — where every detail of preparation, including nutrition strategy, can have a direct impact on performance and recovery.

Cetilar^® Nutrition: the role of the Official Nutrition Partner

Launched in 2023, Cetilar^® Nutrition is Pharmanutra’s advanced sports nutrition line, developed through a scientific approach to meet the specific needs of endurance athletes.

Within the framework of the 2026 Giro d’Italia, the partnership will take shape through co-branding activities, extensive visibility along the race route and in the related formats (Giro d’Italia Women, Giro-E, Giro Next Gen), as well as meaningful opportunities for on-field product testing in one of the world’s most selective and competitive cycling environments.

Thanks to its innovative formulations, carefully selected ingredients, and protocols designed specifically for long-duration sports, Cetilar® Nutrition serves as an ideal technological and scientific partner, supporting athletes throughout the most demanding stages — from the first kilometer to the final sprint in Rome.

Second year of partnership between Pharmanutra and the Giro d’Italia: results and growth

After the first successful year of collaboration, the second year of partnership with the Giro d’Italia represents an important step forward for Pharmanutra in strengthening the brand’s presence within both professional and amateur cycling.

The global exposure offered by the Giro — through international broadcasting, extensive visibility across the territories involved, and the growing prominence of associated races such as the Giro d’Italia Women — provides Cetilar^® Nutrition with a unique platform to:

• bring advanced sports nutrition solutions closer to the wider public;
• reinforce its positioning within the endurance segment;
• enhance the value of ongoing investments in research, development, and product innovation.

“Approaching the second year as Official Nutrition Partner of the Giro d’Italia — in an edition that is so demanding in terms of altitude and mileage — is a significant confirmation of the value of our offering in the endurance sector. The 2026 route, from Bulgaria to Rome, perfectly reflects the international dimension of the Giro and allows us to bring Cetilar^®’s advanced nutrition into direct contact with the heart of global cycling”, comments Roberto Lacorte, Vice President of Pharmanutra S.p.A.